- Home
- CASI vs ANY Comparison
CASI vs ANY Comparison
Compare CASI & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- ANY
- Stock Information
- Founded
- CASI 1991
- ANY N/A
- Country
- CASI China
- ANY United States
- Employees
- CASI N/A
- ANY N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- ANY Finance: Consumer Services
- Sector
- CASI Health Care
- ANY Finance
- Exchange
- CASI Nasdaq
- ANY Nasdaq
- Market Cap
- CASI 24.9M
- ANY 23.8M
- IPO Year
- CASI 1996
- ANY N/A
- Fundamental
- Price
- CASI $1.30
- ANY $0.46
- Analyst Decision
- CASI Strong Buy
- ANY Strong Buy
- Analyst Count
- CASI 1
- ANY 1
- Target Price
- CASI $4.00
- ANY $3.00
- AVG Volume (30 Days)
- CASI 26.7K
- ANY 737.1K
- Earning Date
- CASI 11-14-2025
- ANY 11-04-2025
- Dividend Yield
- CASI N/A
- ANY N/A
- EPS Growth
- CASI N/A
- ANY N/A
- EPS
- CASI N/A
- ANY N/A
- Revenue
- CASI $31,564,000.00
- ANY $11,099,000.00
- Revenue This Year
- CASI N/A
- ANY N/A
- Revenue Next Year
- CASI N/A
- ANY $36.07
- P/E Ratio
- CASI N/A
- ANY N/A
- Revenue Growth
- CASI 36.64
- ANY N/A
- 52 Week Low
- CASI $1.09
- ANY $0.36
- 52 Week High
- CASI $5.95
- ANY $1.67
- Technical
- Relative Strength Index (RSI)
- CASI 35.39
- ANY 27.42
- Support Level
- CASI $1.29
- ANY $0.45
- Resistance Level
- CASI $1.48
- ANY $0.65
- Average True Range (ATR)
- CASI 0.13
- ANY 0.06
- MACD
- CASI -0.00
- ANY -0.02
- Stochastic Oscillator
- CASI 0.00
- ANY 1.46
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.